Company Analysis Sun Pharma Advanced Research Company Limited
1. Summary
Advantages
- Price (218.25 βΉ) is less than fair price (236.35 βΉ)
Disadvantages
- Dividends (0%) are below the sector average (9.55%).
- The stock's return over the last year (-17.04%) is lower than the sector average (28.88%).
- Current debt level 11.87% has increased over 5 years from 0.7399%.
- The company's current efficiency (ROE=-121.28%) is lower than the sector average (ROE=10.72%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Sun Pharma Advanced Research Company Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.2% | -2.2% | -3.9% |
| 90 days | -1.8% | -3.4% | -7.5% |
| 1 year | -17% | 28.9% | 11.4% |
SPARC vs Sector: Sun Pharma Advanced Research Company Limited has significantly underperformed the "Healthcare" sector by -45.92% over the past year.
SPARC vs Market: Sun Pharma Advanced Research Company Limited has significantly underperformed the market by -28.44% over the past year.
Stable price: SPARC is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SPARC with weekly volatility of -0.3277% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (218.25 βΉ) is lower than the fair price (236.35 βΉ).
Price not significantly lower than the fair price: The current price (218.25 βΉ) is slightly lower than the fair price by 8.3%.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (59.64).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (65.67).
4.3. P/BV
P/BV vs Sector: The company's P/BV (97.24) is higher than that of the sector as a whole (6.64).
P/BV vs Market: The company's P/BV (97.24) is higher than that of the market as a whole (6.56).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (161.86) is higher than that of the sector as a whole (9.32).
P/S vs Market: The company's P/S indicator (161.86) is higher than that of the market as a whole (18.88).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-32.92) is lower than that of the sector as a whole (141.59).
EV/Ebitda vs Market: The company's EV/Ebitda (-32.92) is lower than that of the market as a whole (25.22).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 33.25% over the last 5 years.
Accelerating profitability: The return for the last year (73.97%) exceeds the average return for 5 years (33.25%).
Profitability vs Sector: The return for the last year (73.97%) exceeds the return for the sector (-9.37%).
5.4. ROE
ROE vs Sector: The company's ROE (-121.28%) is lower than that of the sector as a whole (10.72%).
ROE vs Market: The company's ROE (-121.28%) is lower than that of the market as a whole (3.38%).
5.5. ROA
ROA vs Sector: The company's ROA (-57.57%) is lower than that of the sector as a whole (7.64%).
ROA vs Market: The company's ROA (-57.57%) is lower than that of the market as a whole (7.93%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.91%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (15.54%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '9.55%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
